Filed 7mo ago· Oct 10, 2025
17 days to disclose
Val T. Hoyle
DHouseOregon-04
↓sold
Johnson & Johnson
JNJ
$1K-$15K
+8.4% vs S&P 500
Trade dateSep 23, 2025
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.

















| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Johnson & Johnson JNJ | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Gilead Sciences GILD | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | GSK PLC GSK | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | AstraZeneca AZN Depositary Shares | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Elanco Animal Health ELAN Common Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Oct 10, 2025 7mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Merck MRK Stock | Sep 23, 2025 17 days to disclose | Flat·+0.0% +8.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | BioNTech BNTX Shares | Aug 7, 2025 36 days to disclose | Flat·+0.0% +15.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↓sold | Eli Lilly LLY | May 6, 2025 129 days to disclose · 84 past 45-day window | Flat·+0.0% +10.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | GSK PLC GSK | Nov 18, 2024 298 days to disclose · 253 past 45-day window | Good buy·+$4K+50.0% +45.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Novo Nordisk NVO | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Bad buy·−$4.6K-57.5% −57.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Bristol-Myers Squibb BMY Common Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$333+4.2% +4.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Johnson & Johnson JNJ | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.8K+47.6% +47.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Gilead Sciences GILD | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3K+38.0% +37.9% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Eli Lilly LLY | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$2.6K+32.4% +32.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | Merck MRK Stock | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$980+12.2% +12.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 12, 2025 8mo ago | ![]() Val T. Hoyle DHouseOregon-04 | ↑bought | AstraZeneca AZN Depositary Shares | Oct 29, 2024 318 days to disclose · 273 past 45-day window | Good buy·+$3.4K+42.9% +42.9% vs S&P 500 | $1K-$15K midpoint $8K |